Boston, Massachusetts – Labviva, the revolutionary AI-powered digital marketplace designed to provide complete transparency into the supply chain of life sciences procurement, today announced it has secured a $20 million Series A round of funding. Led by B Capital Group with additional participation from Glasswing Ventures, Biospring Partners, and Senator Investment Group LP, the financing will be used to accelerate product development and expand its footprint globally. The company is co-founded by Siamak Baharloo.

“At Labviva we are focused on revolutionizing life sciences procurement through our innovative digital marketplace," said Baharloo. “Our goal is to empower informed decisions that drive science forward without interruptions to research. We are excited about this new funding as it will help us accelerate product development and expand our footprint around the globe."

The Labviva platform integrates with existing purchasing software to provide customers with actionable insights they need to make better decisions while keeping current suppliers and contracts to price intact. With unparalleled visibility into their procurement process, customers are able to ensure they have an efficient and cost-effective supply chain for their research needs.